Schedule 13G ownership disclosure

OUTLOOK THERAPEUTICS INC

Common Stock, par value $0.01 per share · CUSIP: 69012T305

Event date: 2025-04-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sphera Funds Management Ltd.

    Shares: 2,571,426 · Class: 7.49%

  • Sphera Global Healthcare GP Ltd.

    Shares: 2,571,426 · Class: 7.49%

  • Sphera Global Healthcare Management LP.

    Shares: 2,571,426 · Class: 7.49%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-25-001278
Form type
SCHEDULE 13G/A
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 10, 2025
Reporting period
Apr 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub